AIM2 and cancer: The abrogation of AIM2 signaling, either in the AIM2-deficient mice or by a pharmacological inhibitor such as thalidomide, significantly reduced the incidence of drug-induced diarrhea without affecting the anti-cancer efficacy of CPT-11 (Lian et al., 2017).